Sagres Discovery Raises $20M in Venture Capital | GenomeWeb

NEW YORK, Oct. 3 – Oncogenomics company Sagres Discovery said Wednesday it had raised $20 million in a second round of private financing.

Sagres of Davis, Calif., said it would use the fresh influx of funds to develop its collection of genes associated with cancer and to form deals with partners to develop antibody and small molecule treatments. The company is also planning to build its senior management and pre-clinical research teams.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."